Page 25 - 2020-2021-Heroes-Program-Bklt-v1_fa_Neat

Nguyen Ly
Nguyen Ly is Executive Director, Biologics Technical Product Leadership at Merck, where he is
responsible for advancing the technical organization to support successful lifecycle management
of the biologics product portfolio. He is also the Keytruda Technical Product Leader. Ly holds a B.S.
in Chemical Engineering from Drexel University.

Gargi Maheshwari
Gargi is Vice President of Cell Therapy Technical Development at Bristol Myers Squibb. She spent
about 20 years at Merck & Co., Inc. working on vaccines and biologics development & manufacturing.
Gargi has a Ph.D. in Chemical Engineering from MIT and B.S. in Biochemical Engineering & Biotechnology
from IIT, Delhi.

Athena Nagi
Athena Nagi, Director of Global Technical Operations, Biologics Technical Product Stewardship,
at Merck, has worked in biologics product development since 1998. She earned a Ph.D. in
Molecular Biophysics and Biochemistry from Yale, and a B.S. in Physics from Binghamton University.

Chakravarthy Narasimham
Nachu Narasimhan is a Senior Principal Scientist at Merck’s Pharmaceutical Sciences division.
He has over 23 years of industry experience in parenteral formulation development and
commercialization including Keytruda®. He received a B.S. from Loyola College, Madras, M.S.
from IIT, Chicago and Ph.D. from Loyola University of Chicago.

Dennis Rendeiro
Dennis Rendeiro has an M.S. in Microbiology and Business Administration from Seton Hall University
and is now retired. Dennis has over 35 years of biotechnology development, manufacturing and
regulatory experience. Dennis guided development activities supporting the upstream
manufacturing process for Merck’s anti-PD1 Keytruda program, including production of preclinical
and clinical supplies, technology transfer for clinical and commercial upstream manufacturing.

#HeroesofChemistry 25